Mental Health

Researchers investigated whether survivors of stroke could take two common types of antidepressant medications—SSRIs and SNRIs—and evaluated if serious bleeding occurred among patients. Their findings were...

Researchers examined how the availability of mental health services and patient specific characteristics impacted levels of anxiety and depression in residents of long-term care settings following COVID-19...

Researchers evaluated the prevalence of depression disorders in pediatric patients to determine if there is a mental health impact on this age group.

Researchers examined trends and patterns of emergency department visits and hospitalizations for suicidality among pediatric patients.

Following two randomized studies, the FDA has approved zuranolone for the treatment of postpartum depression in adults—the first if its kind.

This COVID-19 roundup includes coverage on the FDA-approved oral antiviral treatment for adults with mild-to-moderate COVID-19, how antidepressant medication may lower the incidence of COVID-19, a study...

The USPSTF has updated its recommendations on screening adults for major depressive disorder (MDD) and suicide risk.

This COVID-19 roundup includes a summary of studies on the effective treatment options for patients with long COVID, the risk of patients developing medical or mental health conditions post-hospitalization...

A team of researchers investigated the potential association between mental health disorders and oral health in a cross-sectional and longitudinal analysis.

The United States Preventive Task Force (USPSTF) has recommended, for the first time, that adults be screened for generalized anxiety disorders.